Influences and impact of Anxiety and Depression in the setting of inflammatory bowel disease

Seyedehsan Navabi, Venkata Subhash Gorrepati, Sanjay Yadav, Jaykrishna Chintanaboina, Sarah Maher, Peter Demuth, Benjamin Stern, August Stuart, Andrew Tinsley, Kofi Clarke, Emmanuelle Williams, Matthew Coates

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Individuals with inflammatory bowel disease (IBD) are at increased risk of developing anxiety or depression (A & D). Crohn's disease (CD) and ulcerative colitis (UC) with comorbid A & D are both more challenging to manage. IBD providers need to better understand the causes and impact of A & D in order to improve care for IBD patients. We sought to identify clinical factors that influence development of A & D and healthcare utilization in IBD. Methods: This is a retrospective analysis using an IBD natural history registry from a single tertiary care referral center. Presence of A & D was determined based upon responses to the Hospital Anxiety and Depression Scale. Demographic and clinical factors were abstracted to evaluate for significant associations. Results: Four hundred thirty-two IBD patients (132 UC, 256 CD, and 44 indeterminate colitis) were included in this study. One hundred ninety-two (44.4%) had anxiety or depression or both, and most were female (59.4%, P < 0.05). History of surgery (P < 0.05), female gender (P < 0.05), smoking (P < 0.05), and extra-intestinal manifestations (P < 0.01) were each independently predictive of A & D. Inflammatory bowel disease patients with A & D more often underwent imaging studies (53.6% vs 36.7%, P < 0.05), visited the ED (30.7% vs 20.8%, P < 0.05), or were hospitalized (31.7% vs 21.7%, P < 0.05). They were also more frequently prescribed corticosteroids (50.5% vs 36.7%, P < 0.01) and biologic medications (62.5% vs 51.3%, P < 0.05). Finally, they were more likely to have had at least 1 "no-show" (29.2% vs 16.7%, P < 0.01) and had a higher mean number of "no-shows" (0.69 +/- 0.1 vs 0.30 +/- 0.1, P < 0.01) over the study period. Discussion: Anxiety and depression are common in the setting of IBD and are strongly associated with surgical history, disease complications (including extra-intestinal manifestations), smoking, and female gender. Inflammatory bowel disease patients with A & D are also more likely to require therapy and to utilize healthcare resources. This study refines our understanding of A & D development and its impact in IBD and provides additional considerations for management in this setting.

Original languageEnglish (US)
Pages (from-to)2303-2308
Number of pages6
JournalInflammatory bowel diseases
Volume24
Issue number11
DOIs
StatePublished - Nov 1 2018

Fingerprint

Inflammatory Bowel Diseases
Anxiety
Depression
Ulcerative Colitis
Tertiary Care Centers
Crohn Disease
Smoking
Delivery of Health Care
Colitis
Natural History
Registries
Adrenal Cortex Hormones
History
Demography

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Gastroenterology

Cite this

Navabi, S., Gorrepati, V. S., Yadav, S., Chintanaboina, J., Maher, S., Demuth, P., ... Coates, M. (2018). Influences and impact of Anxiety and Depression in the setting of inflammatory bowel disease. Inflammatory bowel diseases, 24(11), 2303-2308. https://doi.org/10.1093/IBD/IZY143
Navabi, Seyedehsan ; Gorrepati, Venkata Subhash ; Yadav, Sanjay ; Chintanaboina, Jaykrishna ; Maher, Sarah ; Demuth, Peter ; Stern, Benjamin ; Stuart, August ; Tinsley, Andrew ; Clarke, Kofi ; Williams, Emmanuelle ; Coates, Matthew. / Influences and impact of Anxiety and Depression in the setting of inflammatory bowel disease. In: Inflammatory bowel diseases. 2018 ; Vol. 24, No. 11. pp. 2303-2308.
@article{db3bf3f09ae94e24a571ae2f800e6f38,
title = "Influences and impact of Anxiety and Depression in the setting of inflammatory bowel disease",
abstract = "Background: Individuals with inflammatory bowel disease (IBD) are at increased risk of developing anxiety or depression (A & D). Crohn's disease (CD) and ulcerative colitis (UC) with comorbid A & D are both more challenging to manage. IBD providers need to better understand the causes and impact of A & D in order to improve care for IBD patients. We sought to identify clinical factors that influence development of A & D and healthcare utilization in IBD. Methods: This is a retrospective analysis using an IBD natural history registry from a single tertiary care referral center. Presence of A & D was determined based upon responses to the Hospital Anxiety and Depression Scale. Demographic and clinical factors were abstracted to evaluate for significant associations. Results: Four hundred thirty-two IBD patients (132 UC, 256 CD, and 44 indeterminate colitis) were included in this study. One hundred ninety-two (44.4{\%}) had anxiety or depression or both, and most were female (59.4{\%}, P < 0.05). History of surgery (P < 0.05), female gender (P < 0.05), smoking (P < 0.05), and extra-intestinal manifestations (P < 0.01) were each independently predictive of A & D. Inflammatory bowel disease patients with A & D more often underwent imaging studies (53.6{\%} vs 36.7{\%}, P < 0.05), visited the ED (30.7{\%} vs 20.8{\%}, P < 0.05), or were hospitalized (31.7{\%} vs 21.7{\%}, P < 0.05). They were also more frequently prescribed corticosteroids (50.5{\%} vs 36.7{\%}, P < 0.01) and biologic medications (62.5{\%} vs 51.3{\%}, P < 0.05). Finally, they were more likely to have had at least 1 {"}no-show{"} (29.2{\%} vs 16.7{\%}, P < 0.01) and had a higher mean number of {"}no-shows{"} (0.69 +/- 0.1 vs 0.30 +/- 0.1, P < 0.01) over the study period. Discussion: Anxiety and depression are common in the setting of IBD and are strongly associated with surgical history, disease complications (including extra-intestinal manifestations), smoking, and female gender. Inflammatory bowel disease patients with A & D are also more likely to require therapy and to utilize healthcare resources. This study refines our understanding of A & D development and its impact in IBD and provides additional considerations for management in this setting.",
author = "Seyedehsan Navabi and Gorrepati, {Venkata Subhash} and Sanjay Yadav and Jaykrishna Chintanaboina and Sarah Maher and Peter Demuth and Benjamin Stern and August Stuart and Andrew Tinsley and Kofi Clarke and Emmanuelle Williams and Matthew Coates",
year = "2018",
month = "11",
day = "1",
doi = "10.1093/IBD/IZY143",
language = "English (US)",
volume = "24",
pages = "2303--2308",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

Navabi, S, Gorrepati, VS, Yadav, S, Chintanaboina, J, Maher, S, Demuth, P, Stern, B, Stuart, A, Tinsley, A, Clarke, K, Williams, E & Coates, M 2018, 'Influences and impact of Anxiety and Depression in the setting of inflammatory bowel disease', Inflammatory bowel diseases, vol. 24, no. 11, pp. 2303-2308. https://doi.org/10.1093/IBD/IZY143

Influences and impact of Anxiety and Depression in the setting of inflammatory bowel disease. / Navabi, Seyedehsan; Gorrepati, Venkata Subhash; Yadav, Sanjay; Chintanaboina, Jaykrishna; Maher, Sarah; Demuth, Peter; Stern, Benjamin; Stuart, August; Tinsley, Andrew; Clarke, Kofi; Williams, Emmanuelle; Coates, Matthew.

In: Inflammatory bowel diseases, Vol. 24, No. 11, 01.11.2018, p. 2303-2308.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Influences and impact of Anxiety and Depression in the setting of inflammatory bowel disease

AU - Navabi, Seyedehsan

AU - Gorrepati, Venkata Subhash

AU - Yadav, Sanjay

AU - Chintanaboina, Jaykrishna

AU - Maher, Sarah

AU - Demuth, Peter

AU - Stern, Benjamin

AU - Stuart, August

AU - Tinsley, Andrew

AU - Clarke, Kofi

AU - Williams, Emmanuelle

AU - Coates, Matthew

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Background: Individuals with inflammatory bowel disease (IBD) are at increased risk of developing anxiety or depression (A & D). Crohn's disease (CD) and ulcerative colitis (UC) with comorbid A & D are both more challenging to manage. IBD providers need to better understand the causes and impact of A & D in order to improve care for IBD patients. We sought to identify clinical factors that influence development of A & D and healthcare utilization in IBD. Methods: This is a retrospective analysis using an IBD natural history registry from a single tertiary care referral center. Presence of A & D was determined based upon responses to the Hospital Anxiety and Depression Scale. Demographic and clinical factors were abstracted to evaluate for significant associations. Results: Four hundred thirty-two IBD patients (132 UC, 256 CD, and 44 indeterminate colitis) were included in this study. One hundred ninety-two (44.4%) had anxiety or depression or both, and most were female (59.4%, P < 0.05). History of surgery (P < 0.05), female gender (P < 0.05), smoking (P < 0.05), and extra-intestinal manifestations (P < 0.01) were each independently predictive of A & D. Inflammatory bowel disease patients with A & D more often underwent imaging studies (53.6% vs 36.7%, P < 0.05), visited the ED (30.7% vs 20.8%, P < 0.05), or were hospitalized (31.7% vs 21.7%, P < 0.05). They were also more frequently prescribed corticosteroids (50.5% vs 36.7%, P < 0.01) and biologic medications (62.5% vs 51.3%, P < 0.05). Finally, they were more likely to have had at least 1 "no-show" (29.2% vs 16.7%, P < 0.01) and had a higher mean number of "no-shows" (0.69 +/- 0.1 vs 0.30 +/- 0.1, P < 0.01) over the study period. Discussion: Anxiety and depression are common in the setting of IBD and are strongly associated with surgical history, disease complications (including extra-intestinal manifestations), smoking, and female gender. Inflammatory bowel disease patients with A & D are also more likely to require therapy and to utilize healthcare resources. This study refines our understanding of A & D development and its impact in IBD and provides additional considerations for management in this setting.

AB - Background: Individuals with inflammatory bowel disease (IBD) are at increased risk of developing anxiety or depression (A & D). Crohn's disease (CD) and ulcerative colitis (UC) with comorbid A & D are both more challenging to manage. IBD providers need to better understand the causes and impact of A & D in order to improve care for IBD patients. We sought to identify clinical factors that influence development of A & D and healthcare utilization in IBD. Methods: This is a retrospective analysis using an IBD natural history registry from a single tertiary care referral center. Presence of A & D was determined based upon responses to the Hospital Anxiety and Depression Scale. Demographic and clinical factors were abstracted to evaluate for significant associations. Results: Four hundred thirty-two IBD patients (132 UC, 256 CD, and 44 indeterminate colitis) were included in this study. One hundred ninety-two (44.4%) had anxiety or depression or both, and most were female (59.4%, P < 0.05). History of surgery (P < 0.05), female gender (P < 0.05), smoking (P < 0.05), and extra-intestinal manifestations (P < 0.01) were each independently predictive of A & D. Inflammatory bowel disease patients with A & D more often underwent imaging studies (53.6% vs 36.7%, P < 0.05), visited the ED (30.7% vs 20.8%, P < 0.05), or were hospitalized (31.7% vs 21.7%, P < 0.05). They were also more frequently prescribed corticosteroids (50.5% vs 36.7%, P < 0.01) and biologic medications (62.5% vs 51.3%, P < 0.05). Finally, they were more likely to have had at least 1 "no-show" (29.2% vs 16.7%, P < 0.01) and had a higher mean number of "no-shows" (0.69 +/- 0.1 vs 0.30 +/- 0.1, P < 0.01) over the study period. Discussion: Anxiety and depression are common in the setting of IBD and are strongly associated with surgical history, disease complications (including extra-intestinal manifestations), smoking, and female gender. Inflammatory bowel disease patients with A & D are also more likely to require therapy and to utilize healthcare resources. This study refines our understanding of A & D development and its impact in IBD and provides additional considerations for management in this setting.

UR - http://www.scopus.com/inward/record.url?scp=85054892499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054892499&partnerID=8YFLogxK

U2 - 10.1093/IBD/IZY143

DO - 10.1093/IBD/IZY143

M3 - Article

C2 - 29788469

AN - SCOPUS:85054892499

VL - 24

SP - 2303

EP - 2308

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 11

ER -

Navabi S, Gorrepati VS, Yadav S, Chintanaboina J, Maher S, Demuth P et al. Influences and impact of Anxiety and Depression in the setting of inflammatory bowel disease. Inflammatory bowel diseases. 2018 Nov 1;24(11):2303-2308. https://doi.org/10.1093/IBD/IZY143